PPP2R3C Inhibitors

PPP2R3C inhibitors encompass a range of chemical entities that target the phosphatase activity of the protein phosphatase 2 (PP2A) complex, of which PPP2R3C is a regulatory subunit. These inhibitors work by directly binding to the active site of the parent phosphatase PP2A or altering its substrate specificity and dephosphorylation dynamics, which in turn impairs the function of PPP2R3C. By impeding the dephosphorylation of key proteins and signaling molecules, the inhibitors contribute to the dysregulation of cellular processes in which PPP2R3C is implicated. Some inhibitors exert their effects by mimicking natural toxin structures, binding to the PP2A catalytic core and distorting its conformation, thus leading to the inhibition of PPP2R3C's regulatory role. Others operate by modulating the interaction between the PP2A core enzyme and PPP2R3C, hindering the assembly of the functional holoenzyme complex, which is essential for PPP2R3C to exert its regulatory effects on dephosphorylation processes.

Additionally, certain inhibitors target related serine/threonine phosphatases, achieving an indirect inhibitory effect on PPP2R3C by reducing the overall phosphatase activity within the cell. This can lead to a sustained phosphorylated state of proteins that would otherwise be substrates for the PP2A complex, altering the signaling pathways and cellular functions that PPP2R3C helps to regulate. Some inhibitors achieve this by structurally interfering with the active site of the enzyme, while others affect the regulatory protein interactions that define phosphatase specificity and function. Moreover, some molecules disrupt intracellular transport mechanisms, potentially affecting the correct localization and functioning of PPP2R3C within the cell.